BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31322623)

  • 21. Safety of cardiac surgery without blood transfusion: a retrospective study in Jehovah's Witness patients.
    El Azab SR; Vrakking R; Verhage G; Rosseel PM
    Anaesthesia; 2010 Apr; 65(4):348-52. PubMed ID: 20402872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.
    Coltoff A; Shreenivas A; Afshar S; Steinberg A
    Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):44-49. PubMed ID: 30605629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
    Ford PA; Grant SJ; Mick R; Keck G
    J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral sequential lung transplantation in Jehovah's Witnesses.
    Chan EG; Morrell MR; Chan PG; Sanchez PG
    Perfusion; 2021 Oct; 36(7):672-676. PubMed ID: 32650703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical issues in solid organ transplantation: transfusion-free transplantation in Jehovah's witness patients.
    Selby R; Selby-Medical T; Richman M
    Curr Opin Organ Transplant; 2024 Feb; 29(1):82-87. PubMed ID: 38054541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute leukaemia in adult Jehovah's Witnesses.
    El Chaer F; Ballen KK
    Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic modalities in thrombotic thrombocytopenic purpura management among Jehovah's Witness patients: A review of reported cases.
    Tran MH
    Transfus Apher Sci; 2023 Aug; 62(4):103706. PubMed ID: 36990894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Jehovah's Witness Population: Considerations for Preoperative Optimization of Hemoglobin.
    Campbell YN; Machan MD; Fisher MD
    AANA J; 2016 Jun; 84(3):173-8. PubMed ID: 27501652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bloodless Repair of Aortic Arch with Dual Aortic Cannulation in a Jehovah's Witness Patient.
    Valleley MS; Glogowski KR; Duncan KF; Dutoit A; Hagedorn C
    J Extra Corpor Technol; 2017 Sep; 49(3):206-209. PubMed ID: 28979046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
    Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Jehovah's Witnesses with hematological malignancies treated without transfusions - single center experience.
    Drozd-Sokołowska JE; Waszczuk-Gajda A; Dwilewicz-Trojaczek J; Walesiak A; Krzyżanowska M; Paluszewska M; Wieczorek J; Jędrzejczak WW
    Folia Med Cracov; 2020; 60(4):53-64. PubMed ID: 33821851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood component support in patients with solid tumors and hematologic malignancies: lessons from the treatment of Jehovah's Witnesses.
    Benson K
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):858-60. PubMed ID: 25674845
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical strategies in the medical care of Jehovah's Witnesses.
    Remmers PA; Speer AJ
    Am J Med; 2006 Dec; 119(12):1013-8. PubMed ID: 17145240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
    Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
    Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotherapy and the Fundamentalist client: the aims and challenges of treating Jehovah's Witnesses.
    Friedson ML
    J Relig Health; 2015 Apr; 54(2):693-712. PubMed ID: 25261980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Care of the injured Jehovah's Witness patient: case report and review of the literature.
    Kulvatunyou N; Heard SO
    J Clin Anesth; 2004 Nov; 16(7):548-53. PubMed ID: 15590263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute normovolemic hemodilution in a Jehovah's Witness patient: a case report.
    Lindstrom E; Johnstone R
    AANA J; 2010 Aug; 78(4):326-30. PubMed ID: 20879634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness.
    Devich R; Neuendorff NR; Frazier OH; Eisen HJ; Dowling R; Freundt M
    ASAIO J; 2023 Aug; 69(8):e384-e387. PubMed ID: 37084256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.